Early and intensive treatment: glycaemic control in type 2 diabetes
Diab Vasc Dis Res 2006 3: 145-146. [PDF] [References] [Request Permission]  

Ramzi A Ajjan and Peter J Grant

Cardiovascular disease prevention in patients with type 2 diabetes: the role of oral anti-diabetic agents
Diab Vasc Dis Res 2006 3: 147-158. [Abstract] [PDF] [References] [Request Permission]  

Brian D Green, Peter R Flatt, and Clifford J Bailey

Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes
Diab Vasc Dis Res 2006 3: 159-165. [Abstract] [PDF] [References] [Request Permission]  

Anthony S Wierzbicki

Fibrates after the FIELD study: some answers, more questions
Diab Vasc Dis Res 2006 3: 166-171. [Abstract] [PDF] [References] [Request Permission]  

Iskandar Idris and Richard Donnelly

Protein kinase C β inhibition: a novel therapeutic strategy for diabetic microangiopathy
Diab Vasc Dis Res 2006 3: 172-178. [Abstract] [PDF] [References] [Request Permission]  

Srikanth Bellary and Anthony H Barnett

Inhaled insulin (Exubera®): combining efficacy and convenience
Diab Vasc Dis Res 2006 3: 179-185. [Abstract] [PDF] [References] [Request Permission]  

Dawn K Coletta, Sarah H Bates, Robert B Jones, and Clifford J Bailey

The sibutramine metabolite M2 improves muscle glucose uptake and reduces hepatic glucose output: preliminary data
Diab Vasc Dis Res 2006 3: 186-188. [Abstract] [PDF] [References] [Request Permission]  

Dahong Yu, Susan J Murdoch, Shamik J Parikh, Santica M Marcovina, Alexander Cobitz, Hongzi Chen, and John D Brunzell

Rosiglitazone increases LDL particle size and buoyancy and decreases C-reactive protein in patients with type 2 diabetes on statin therapy
Diab Vasc Dis Res 2006 3: 189-196. [Abstract] [PDF] [References] [Request Permission]  

Berhane Seyoum, Raymond O Estacio, Paulos Berhanu, and Robert W. Schrier

Exercise capacity is a predictor of cardiovascular events in patients with type 2 diabetes mellitus
Diab Vasc Dis Res 2006 3: 197-201. [Abstract] [PDF] [References] [Request Permission]  

George A. Bray

Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study
Diab Vasc Dis Res 2006 3: 202-215. [Abstract] [PDF] [References] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.